BMY
Bristol-Myers Squibb Company
- Total liabilities, 2025
- $71.5B
- YoY, 2025
- −6.1%
- 5-year CAGR
- −2.4%
- 10-year CAGR
- +15.2%
Total liabilities
Total liabilities by fiscal year
| Period | Total liabilities | YoY |
|---|---|---|
| 2025 | $71.5B | −6.1% |
| 2024 | $76.2B | +16.1% |
| 2023 | $65.7B | 0.0% |
| 2022 | $65.7B | −10.4% |
| 2021 | $73.3B | −9.0% |
| 2020 | $80.6B | +3.0% |
| 2019 | $78.2B | +275.1% |
| 2018 | $20.9B | −3.9% |
| 2017 | $21.7B | +25.0% |
| 2016 | $17.4B | +0.2% |
| 2015 | $17.3B | −7.7% |
| 2014 | $18.8B | −19.7% |
| 2013 | $23.4B | +4.9% |
| 2012 | $22.3B | +30.1% |
| 2011 | $17.1B | +10.8% |
| 2010 | $15.4B | −4.8% |
| 2009 | $16.2B | −6.1% |
| 2008 | $17.3B | — |